Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
1986-9-17
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Aug
|
| pubmed:issn |
0028-4793
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
7
|
| pubmed:volume |
315
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
393-4
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:3016538-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:3016538-Antigens, Viral,
pubmed-meshheading:3016538-Deltaretrovirus,
pubmed-meshheading:3016538-HIV Antigens,
pubmed-meshheading:3016538-Humans,
pubmed-meshheading:3016538-Immune Tolerance,
pubmed-meshheading:3016538-Lymphocyte Activation
|
| pubmed:year |
1986
|
| pubmed:articleTitle |
Impaired specific cellular response to HTLV-III before other immune defects in patients with HTLV-III infection.
|
| pubmed:publicationType |
Letter
|